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574a Wednesday, February 11, 2015compound exposure. The inhibition profile of PF-05089771 suggests that a
conformational change in the Domain 4 VSD couples to multiple downstream
inactivated states and immobilizing the voltage-sensor via a small molecule
interaction with this site may lock the channel into long term inactivation
from which recovery is slow.
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Mutations in voltage-gated sodium (Nav) channel isoforms are correlated with
a wide range of cardiovascular and neurological diseases in humans, and are
therefore are important targets for the rational design of novel drugs. The
cardiac isoform of the Nav channel, Nav1.5, presents a unique target for the
development of antiarrhythmic drugs. In this work, we identify key structural
motifs for local anesthetic binding in the pore-domain of the open and closed
states of the human Nav1.5 channel. The Rosetta structural modeling method
was used to construct models of human Nav1.5 isoform based on the 3D crystal
structures of bacterial Nav channels: NavRh (closed state) and NavMs (open
state). The resulting lowest free-energy models were selected for local anes-
thetic docking simulations. Rosetta loop modeling and global relaxation of
10,000 models yielded a convergent motif in the selectivity filter region of a
stabilizing hydrogen bond network between Tryptophan and Threonine pairs.
A membrane-facing fenestration near the S6 helix of domain IV and the S5 he-
lix of domain III was also structurally conserved, and is a proposed site of
neutral drug entry. Docking simulations of the channel blocker, lidocaine,
reveal key protein-ligand binding configurations within the pore. Our prelimi-
nary models of the human Nav1.5 channel in the open and closed states reveal
highly conserved structural motifs important for both stabilization of the pore
domain, as well as for drug entry and binding. Future work will use structural
models of drug interaction with human Nav1.5 as a dynamic testing platform
for the calculation of the kinetics of drug binding and unbinding.
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Voltage gated sodium (Nav) channels are responsible for initiation and propa-
gation of action potentials in nerve and muscle. Due to their physiological roles,
Nav channels are prime targets of natural toxins from a variety of organisms
such as spiders, scorpions, snakes and cone snails. ProTx-II, from the tarantula
Thrixopelma prurient, is a 30-residue peptide toxin that is a potent inhibitor of
Nav channels. It binds to voltage sensor domains (VSDs) II and IV of human
Nav1.7 channels. It is more than 100-fold selective for Nav1.7 versus all other
human Nav channel isoforms. Magi-5, from Macrothele gigas, is a 29-residue
peptide toxin that stabilizes an activated state of the domain II VSD of Nav
channels. Both spider toxins share a structural fold stabilized by the same disul-
fide bridge network, yet they have opposite effects on Nav function: ProTx-II
stabilizes a resting state of VSDII, while Magi-5 stabilizes an activated state.
We use solid phase peptide synthesis to generate ProTx-II - Magi-5 chimeras
by inserting loop regions between conserved cystines of Magi-5 into ProTx-
II. Molecular modeling, protein-protein docking and electrophysiology tech-
niques are used to identify critical residues responsible for opposite effects
of ProTx-II and Magi-5 on Nav channel function. Our findings may be useful
in the design of novel modulators of human Nav1.7 channel and may elucidate
important structural determinants of VSD toxin activity.
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Fibroblast growth factor 14 (FGF14) is a functionally relevant accessory protein
of the neuronal Nav channel. Through a monomeric interaction with the intra-
cellular C-terminus of neuronal Nav channels, FGF14 modulates Naþ currents
in a Nav isoform-specific manner serving as a fine-tuning regulator of excit-
ability. In previous studies we have reconstituted the PPI interaction of
FGF14 andNav1.6 in live cells using the split-luciferase complementation assay(LCA) and through site-direct mutagenesis identified ‘‘hot-spots’’ at the FGF14
surface critical for binding to Nav1.6. Based on the FGF14 monomer structure
generated in silico, we have designed short peptide fragments that align with
pockets defined by the FGF14 b12-strand and b8-b9 loop and validated their
in-cell activity as inhibitors of the FGF14:Nav1.6 complex. We then applied
patch-clamp electrophysiology and show exciting preliminary data indicating
that two peptides, Fpep1 and Epep1, exhibit either a negative allosteric modu-
lators (NAM)-like or a positive allosteric modulators (PAM)-like activity
against Nav1.6-encoded currents. For one peptide, Fpep1, we have begun me-
dicinal chemistry efforts to generate novel peptidomimetics that are currently
being evaluated. These breakthrough results identify the FGF14 b8-b9 and
b12 as part of potential druggable pockets against the FGF14-Nav1.6 complex
and indicate that small molecule inhibitors (SMI) and/or peptidomimetics
targeting these pockets might give rise to a new class of unconventional PPI-
based allosteric modulators of Nav channels that could restore dysfunction of
neuronal excitability and plasticity in brain disorders. These results provide
fundamental new knowledge for the design of new leads targeting the Nav chan-
nel macromolecular complex. We expect our studies to have a broad impact in
the drug design against a wide range of still untreatable brain disorders
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Voltage-gated sodium channels play essential roles in electrical signaling in the
nervous system and are key pharmacological targets. We have carried out
multi-microsecond Anton simulations of the bacterial NavAb channel to reveal
ion conduction intimately connected with conformational fluctuations of the
protein pore (C Boiteux, I Vorobyov & TW Allen, 2014 PNAS 111:3454),
and a multiple-ion mechanism underlying Naþ versus Kþ selectivity. We
observe collapse of the pore domain, involving residues identified in pore-
based slow inactivation and drug binding in prokaryotic and eukaryotic chan-
nels. We demonstrate high affinity binding of anti-epileptic and local anesthetic
drugs to F203, that is a surrogate for the highly conserved FS6 in mammalian
sodium channels, as well as low affinity sites with potential roles in channel
inhibition. We observe two drug access pathways, including a previously
suggested lipophilic route via membrane-bound fenestrations, and an aqueous
pathway through the channel pore, despite being closed (C Boiteux, et al. 2014
PNAS 111:13057). These studies provide new insight into Nav function and
modulation, and predictions to assist future drug development.
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Although extensive electrophysiological characterization is available for eu-
karyotic voltage-gated Naþ channels (Nav), no high-resolution structures of
these channels are available. Crystal structures of several bacterial Nav chan-
nels have been published and molecular dynamics simulations of ion perme-
ation through these channels are consistent with many electrophysiological
properties of the eukaryotic channels. Unlike eukaryotic Nav channels, howev-
er, the bacterial Nav channels are strongly outwardly rectifying, and the mech-
anism of this rectification has not previously been described. We used step-wise
pulling protocols to implement Jarzynski’s Equality in non-equilibrium molec-
ular dynamics simulations of ion permeation through the bacterial NavAb
channel to obtain a mechanistic description of this outward rectification.
Results of the simulations indicate that two or three extracellular Kþ ions
bind tightly at the same z-coordinate along the selectivity filter of NavAb
and can effectively block the channel in the presence of modest voltages or con-
centration driving forces. The configuration with two potassium ions located at
the same z-coordinate is also found in the two-dimensional potential of mean
forces generated from umbrella sampling and weighted histogram analysis.
In contrast to Kþ, three Naþ ions move through the selectivity filter together
